Rigel Pharmaceuticals
RIGL
RIGL
117 hedge funds and large institutions have $490M invested in Rigel Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 19 closing their positions.
Holders
117
Holders Change
-4
Holders Change %
-3.31%
% of All Funds
2.69%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
44
Reduced
31
Closed
19
Calls
$8.8M
Puts
$5.09M
Net Calls
+$3.71M
Net Calls Change
+$2.62M
Top Buyers
| 1 |
BC
1
Boxer Capital
San Diego,
California
|
$18.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$17.7M |
| 3 |
3
Citigroup
New York
|
$3.51M |
| 4 |
GPP
4
Great Point Partners
Greenwich,
Connecticut
|
$30.4M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$7.16M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$14.2M |
| 2 |
SCM
2
Sio Capital Management
New York
|
$0 |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$11.2M |
| 4 |
GTC
4
Ghost Tree Capital
New York
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.91M |
